Arcadia Biosciences, Inc. (RKDA) Financial Statements (2024 and earlier)

Company Profile

Business Address 202 COUSTEAU PLACE
DAVIS, 95618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 01 - Agricultural Production Crops (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,50722,99820,64422,71921,23424,551
Cash and cash equivalents13,48422,99820,64422,71921,23424,551
Short-term investments5,023     
Receivables (1)(18)(3)(13)3,8542,768
Inventory, net of allowances, customer advances and progress billings3,1642,5912,5713,3423,2753,235
Inventory3,1642,5912,5713,3423,2753,235
Disposal group, including discontinued operation      
Asset, held-for-sale, not part of disposal group878787254254254
Other undisclosed current assets1,5821,5472,0993,7291,441691
Total current assets:23,33927,20525,39830,03130,05831,499
Noncurrent Assets
Inventory, Noncurrent1,2977607679841,1362,656
Operating lease, right-of-use asset1,3841,6181,8482,0732,3082,546
Property, plant and equipment5606227048489541,468
Intangible assets, net (including goodwill)404040373386471
Intangible assets, net (excluding goodwill)404040373386471
Other noncurrent assets178165165165166159
Total noncurrent assets:3,4593,2053,5244,4434,9507,300
TOTAL ASSETS:26,79830,41028,92234,47435,00838,799
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,7832,7852,8812,7483,3913,440
Accounts payable   931   
Accrued liabilities   1,746   
Other undisclosed accounts payable and accrued liabilities2,7832,7852042,7483,3913,440
Disposal group, including discontinued operation      
Due to related parties1548478369
Other liabilities  283270270272264
Other undisclosed current liabilities1,3081,0141,0109869941,036
Total current liabilities:4,0914,0974,2094,0514,7404,809
Noncurrent Liabilities
Long-term debt and lease obligation:    1,2691,5001,709
Liabilities, other than long-term debt2,5322,7603,0072,0002,0002,039
Other liabilities2,0002,0002,0002,0002,0002,039
Operating lease, liability5327601,0071,2691,5001,709
Other undisclosed noncurrent liabilities2,4456,8618062,135  
Total noncurrent liabilities:4,9779,6213,8135,4043,5003,748
Total liabilities:9,06813,7188,0229,4558,2408,557
Equity
Equity, attributable to parent17,86816,82521,03325,06826,80730,261
Common stock656565656363
Additional paid in capital284,202284,003278,827278,618277,492277,169
Accumulated other comprehensive income21     
Accumulated deficit(266,420)(267,243)(257,859)(253,615)(250,748)(246,971)
Equity, attributable to noncontrolling interest(138)(133)(133)(49)(39)(19)
Total equity:17,73016,69220,90025,01926,76830,242
TOTAL LIABILITIES AND EQUITY:26,79830,41028,92234,47435,00838,799

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues1,3891,5091,0001,8783,8583,220
Cost of revenue
(Cost of Goods and Services Sold)
(981)(825)(1,552)(1,344)(3,447)(3,458)
Gross profit:408684(552)534411(238)
Operating expenses(4,199)(4,732)(4,714)(5,114)(5,011)(4,744)
Other undisclosed operating income (loss)   (564) 817359
Operating loss:(3,791)(4,048)(5,830)(4,580)(3,783)(4,623)
Nonoperating income (expense)(13)3220431,09414
Investment income, nonoperating     1,138 
Other nonoperating income (expense)(13)322043(44)14
Interest and debt expense      (1)
Loss from continuing operations before equity method investments, income taxes:(3,804)(4,016)(5,810)(4,537)(2,689)(4,610)
Other undisclosed income from continuing operations before income taxes  3,184   
Loss from continuing operations before income taxes:(3,804)(4,016)(2,626)(4,537)(2,689)(4,610)
Income tax expense (1) (13)(1)  
Loss from continuing operations:(3,805)(4,016)(2,639)(4,538)(2,689)(4,610)
Loss before gain (loss) on sale of properties:(4,538)(2,689)(4,610)
Loss from discontinued operations      
Other undisclosed net income (loss) 4,623(5,368)(1,689)1,661(1,108) 
Net income (loss):818(9,384)(4,328)(2,877)(3,797)(4,610)
Net income attributable to noncontrolling interest 5 841020122
Net income (loss) available to common stockholders, diluted:823(9,384)(4,244)(2,867)(3,777)(4,488)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):818(9,384)(4,328)(2,877)(3,797)(4,610)
Other comprehensive income21     
Comprehensive income (loss):839(9,384)(4,328)(2,877)(3,797)(4,610)
Comprehensive income, net of tax, attributable to noncontrolling interest 5 841020122
Comprehensive income (loss), net of tax, attributable to parent:844(9,384)(4,244)(2,867)(3,777)(4,488)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: